NPPA fixes retail price of 40 formulations - Video

Published On 2022-10-05T16:21:11+05:30 | Updated On 5 Oct 2022 4:21 PM IST

Overview

Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 40 new drugs, including those used to treat high blood pressure, type 2 diabetes, certain types of stomach cancer, bacterial infections, and those used to relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, muscle pain, bone pain, and joint pain.

These include Akums Drugs, Cipla's Metoprolol Succinate (as Extended Release), Chlorthalidone, and Telmisartan fixed-dose combination tablets, Akums Drugs, Apex Laboratories' Mefenamic Acid and Paracetamol Oral Suspension, Windlas Biotech, Micro Lab's Nebivolol Hydrochloride and Telmisartan Tablet, Ahlcon Parenterals, SunPharmaceutical's Budesonide Nebuliser Suspension BP 0.5mg/2m, and Skymap Pharmaceuticals' Clopidogrel and Aspirin Tablets.

For more details, check out the link given below:

NPPA Fixes Retail Price Of 40 Formulations Including Dapagliflozin-Metformin FDC

Speakers

Roshni Dhar

Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751